In the last trading session, 2.51 million shares of the Eterna Therapeutics Inc (NASDAQ:ERNA) were traded, and its beta was 4.32. Most recently the company’s share price was $0.42, and it changed around -$0.03 or -5.97% from the last close, which brings the market valuation of the company to $21.69M. ERNA currently trades at a discount to its 52-week high of $2.62, offering almost -523.81% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 47.62% since then. We note from Eterna Therapeutics Inc’s average daily trading volume that its 10-day average is 60.44 million shares, with the 3-month average coming to 10.55 million.
Eterna Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ERNA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Eterna Therapeutics Inc (NASDAQ:ERNA) trade information
Instantly ERNA has showed a red trend with a performance of -5.97% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.9600 on recent trading dayincreased the stock’s daily price by 56.25%. The company’s shares are currently up 43.61% year-to-date, but still up 40.73% over the last five days. On the other hand, Eterna Therapeutics Inc (NASDAQ:ERNA) is 55.45% up in the 30-day period. We can see from the shorts that 44458.0 shares have been sold at a short interest cover period of 1.07 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 0.06%.
ERNA Dividends
Eterna Therapeutics Inc’s next quarterly earnings report is expected to be released in February.
Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 336.35% of Eterna Therapeutics Inc shares, and 11.00% of them are in the hands of institutional investors. The stock currently has a share float of -4.65%.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 26.1 shares worth $11018.0, making up 0.05% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 13.1 shares worth around $5529.0, which represents about 0.03% of the total shares outstanding.
